USPTO serial 88493571
CENTOLSD
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- ALAO, OREOLUWA
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CENTOLSD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Angela P. Doughty
Angela P. Doughty WARD AND SMITH, P.A.751 CORPORATE CENTER DRIVEPOST OFFICE BOX 33009RALEIGH, NC 27636-3009Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | scientific, surveying, weighing, measuring and checking apparatus and instruments, namely, fluorometers, spectrophotometers, real-time polymerase chain reaction (PCR) devices for gene expression and genotyping, DNA analyzers, DNA fragmentation and capture devices, thermal cycler, and thermal blocks for incubations all to determine the structure, composition or sequence of DNA on multiple genes or on the whole genomic coding region or the whole genome, to determine structure, composition or sequence of RNA and for biochemical measurements of biomarkers; apparatus and instruments for scientific research in laboratories, namely, scientific devices to determine DNA or RNA sequence, alterations, rearrangements, copy number variations, and deletions; apparatus and instruments for scientific research in laboratories, namely, devices to determine biochemical markers, namely, fluorometers, spectrophotometers, real-time polymerase chain reaction (PCR) devices for gene expression and genotyping, DNA analyzers, and DNA fragmentation and capture devices all for scientific purposes; apparatus and instruments for scientific research in laboratories, namely, devices to prepare respective biological samples for acquiring measurements, namely, thermal cyclers, thermal blocks, magnetic beads, pipetting tips, microcentrifuge tubes, and 96-well microplates; pre-recorded compact discs, DVDs, and other digital recording media, namely, downloadable audio and video digital recordings, and digital video media, all featuring clinical phenotypic, genetic molecular and demographic information; computers; downloadable computer software for database management and for managing, analyzing, interpreting and storing the data obtained from laboratory instruments | ACTIVE | — |
| 035 | collating and systematic ordering of data in a computer database, namely, database management and computerized file management; computerized file management; industrial analysis services, namely, industrial management consultation including cost/yield analyses and marketing research services | ACTIVE | — |
| 042 | scientific and technological services namely, genetic and biochemical analytical testing for scientific research purposes and new product research and design relating thereto; industrial analysis services and provision of research services in the field of genetics and in the field of pharmaceutical development; scientific research for medical purposes in the field of hereditary diseases, oncology, and complex genetics related diseases; design and development of computer hardware and computer software; services of a medical laboratory; medical laboratory services for the analysis of samples taken from patients; provision of information in the field of pharmacology; providing online non-downloadable computer software for database management and for managing, analyzing, interpreting and storing the data obtained from laboratory instruments | ACTIVE | — |
| 044 | medical and veterinary services, in particular, medical analysis in connection with the treatment of individuals; providing information in the fields of medicine and veterinary medicine; health center services, namely, genetic centers providing medical diagnostic, preventive and curative therapy services for genetic disorders, cancer treatment centers, rare disease treatment centers, children's hospitals and women's hospital; medical clinic services; medical clinic services, namely, medical testing of blood, biological tissue, saliva, urine and hair follicles; gene therapy services in the field of oncology, infertility, prenatal diagnostics, carrier testing, and genetically inherited diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CENTOGENE GMBH
- Other trademarks owned by Centogene AG
- Other trademarks owned by Centogene AG
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CENTOLSD
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 28, 2022 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 28, 2022 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 1, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 29, 2021 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jun 29, 2021 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jun 29, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 24, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 22, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 22, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 22, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 11, 2020 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jul 28, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 2, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 2, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 13, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 29, 2020 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 28, 2020 | ALIE | ASSIGNED TO LIE | — |
| Apr 22, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 21, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 21, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 21, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 21, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 11, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 11, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 11, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 17, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 17, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 17, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 25, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 25, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 25, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 18, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 9, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 2, 2019 | NWAP | NEW APPLICATION ENTERED | — |